Autophagy in malignant transformation and cancer progression.

• Galluzzi L Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France INSERM U1138, Paris, France Gustave Roussy Cancer Campus, Villejuif, France Université Paris Descartes Sorbonne Paris Cité, Paris, France deadoc@vodafone.it.
• Pietrocola F Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France INSERM U1138, Paris, France Gustave Roussy Cancer Campus, Villejuif, France.
• Bravo-San Pedro JM Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France INSERM U1138, Paris, France Gustave Roussy Cancer Campus, Villejuif, France.
• Amaravadi RK Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
• Baehrecke EH Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, USA.
• Cecconi F Cell Stress and Survival Unit, Danish Cancer Society Research Center, Copenhagen, Denmark IRCCS Fondazione Santa Lucia and Department of Biology University of Rome Tor Vergata, Rome, Italy.
• Codogno P Université Paris Descartes Sorbonne Paris Cité, Paris, France Institut Necker Enfants-Malades (INEM), Paris, France INSERM U1151, Paris, France CNRS UMR8253, Paris, France.
• Debnath J Department of Pathology and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
• Gewirtz DA Department of Pharmacology, Toxicology and Medicine, Virginia Commonwealth University, Richmond Virginia, VA, USA.
• Karantza V Merck Research Laboratories, Rahway, NJ, USA.
• Kimmelman A Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
• Kumar S Centre for Cancer Biology, University of South Australia, Adelaide, SA, Australia.
• Levine B Center for Autophagy Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
• Maiuri MC Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France INSERM U1138, Paris, France Gustave Roussy Cancer Campus, Villejuif, France.
• Martin SJ Department of Genetics, Trinity College, The Smurfit Institute, Dublin, Ireland.
• Penninger J Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
• Piacentini M Department of Biology, University of Rome Tor Vergata, Rome, Italy National Institute for Infectious Diseases IRCCS 'Lazzaro Spallanzani', Rome, Italy.
• Rubinsztein DC Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
• Simon HU Institute of Pharmacology, University of Bern, Bern, Switzerland.
• Simonsen A Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
• Thorburn AM Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA.
• Velasco G Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University of Madrid, Madrid, Spain Instituto de Investigaciones Sanitarias San Carlos (IdISSC), Madrid, Spain.
• Ryan KM Cancer Research UK Beatson Institute, Glasgow, UK.
• Kroemer G Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France INSERM U1138, Paris, France Université Paris Descartes Sorbonne Paris Cité, Paris, France Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.

Show more…

Beclin 1

KRAS

adaptive stress responses

inflammation

mitophagy

Animals

Autophagy

Cell Transformation, Neoplastic

Humans

Neoplasms

Tumor Escape

Tumor Suppressor Proteins